Common and distinct functions of mouse Dot1l in the regulation of endothelial transcriptome

被引:1
|
作者
Yoo, Hyunjin [1 ]
La, Hyeonwoo [1 ]
Park, Chanhyeok [1 ]
Yoo, Seonho [1 ]
Lee, Hyeonji [1 ]
Song, Hyuk [1 ]
Do, Jeong Tae [1 ]
Choi, Youngsok [1 ]
Hong, Kwonho [1 ]
机构
[1] Konkuk Univ, Inst Adv Regenerat Sci, Dept Stem Cell & Regenerat Biotechnol, Seoul, South Korea
关键词
blood endothelial cell; lymphatic endothelial cell; epigenetics; DOT1l; transcriptional regulation; PHENOTYPIC HETEROGENEITY; EPIGENETIC REGULATION; DETAILED DISTRIBUTION; H3K79; METHYLATION; CELLS; EXPRESSION; ORIGIN; LYMPHANGIOGENESIS; PROTOCADHERINS; CONTRIBUTES;
D O I
10.3389/fcell.2023.1176115
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epigenetic mechanisms are mandatory for endothelial called lymphangioblasts during cardiovascular development. Dot1l-mediated gene transcription in mice is essential for the development and function of lymphatic ECs (LECs). The role of Dot1l in the development and function of blood ECs blood endothelial cells is unclear. RNA-seq datasets from Dot1l-depleted or -overexpressing BECs and LECs were used to comprehensively analyze regulatory networks of gene transcription and pathways. Dot1l depletion in BECs changed the expression of genes involved in cell-to-cell adhesion and immunity-related biological processes. Dot1l overexpression modified the expression of genes involved in different types of cell-to-cell adhesion and angiogenesis-related biological processes. Genes involved in specific tissue development-related biological pathways were altered in Dot1l-depleted BECs and LECs. Dot1l overexpression altered ion transportation-related genes in BECs and immune response regulation-related genes in LECs. Importantly, Dot1l overexpression in BECs led to the expression of genes related to the angiogenesis and increased expression of MAPK signaling pathways related was found in both Dot1l-overexpressing BECs and LECs. Therefore, our integrated analyses of transcriptomics in Dot1l-depleted and Dot1l-overexpressed ECs demonstrate the unique transcriptomic program of ECs and the differential functions of Dot1l in the regulation of gene transcription in BECs and LECs.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Maternal DOT1L is dispensable for mouse development
    Ji Liao
    Piroska E. Szabó
    Scientific Reports, 10
  • [2] Maternal DOT1L is dispensable for mouse development
    Liao, Ji
    Szabo, Piroska E.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L
    Geunyeong Park
    Zihua Gong
    Junjie Chen
    Ja-Eun Kim
    The Protein Journal, 2010, 29 : 213 - 223
  • [4] Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L
    Park, Geunyeong
    Gong, Zihua
    Chen, Junjie
    Kim, Ja-Eun
    PROTEIN JOURNAL, 2010, 29 (03): : 213 - 223
  • [5] INHIBITION OF DOT1L ACTIVITY IN HUMAN SKIN FIBROBLASTS: A TRANSCRIPTOME ANALYSIS
    Berghen, Nathalie
    De langhe, Ellen
    Lories, Rik
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1557 - 1557
  • [6] Primitive Erythropoiesis in the Mouse is Independent of DOT1L Methyltransferase Activity
    Malcom, Carrie A.
    Ratri, Anamika
    Piasecka-Srader, Joanna
    Borosha, Shaon
    Chakravarthi, V. Praveen
    Alvarez, Nehemiah S.
    Vivian, Jay L.
    Fields, Timothy A.
    Karim Rumi, M. A.
    Fields, Patrick E.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [7] New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse
    Stauffer, Frederic
    Weiss, Andreas
    Scheufler, Clemens
    Moebitz, Henrik
    Ragot, Christian
    Beyer, Kim S.
    Calkins, Keith
    Guthy, Daniel
    Kiffe, Michael
    Van Eerdenbrugh, Bernard
    Tiedt, Ralph
    Gaul, Christoph
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12): : 1655 - 1660
  • [8] Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development
    Barry, Evan R.
    Corry, Gareth N.
    Rasmussen, Theodore P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (04) : 405 - 418
  • [9] DOT1L in prostate cancer
    Tim Thomas
    Nature Reviews Urology, 2020, 17 : 544 - 544
  • [10] DOT1L inhibition alters transcriptome and epigenome signatures in breast cancer cells
    Suzuki, Hiromu
    Maruyama, Reo
    Kitajima, Hiroshi
    Niinuma, Takeshi
    Ishiguro, Kazuya
    Kumegawa, Kohei
    Yoshido, Ayano
    Sasaki, Hajime
    Yamamoto, Eiichiro
    Kai, Masahiro
    Nakase, Hiroshi
    CANCER SCIENCE, 2022, 113 : 509 - 509